'Sputnik V provides immunity for a longer duration'

'Its efficacy is 97.6 per cent.'   Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......

India to produce 850mn Sputnik doses annually: RDIF

The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......

India to have 5 more COVID vaccines by Oct, Sputnik expected to get emergency use nod in 10 days

As more and more states flag shortage of COVID-19 vaccine doses, the Central government has pressed the accelerator to scale up vaccine production manifold. Top government sources said that by end......

Sputnik V vaccine may be added to India's Covid armoury soon

‘We expect to get the approval in the next few weeks,’ says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL). IMAGE: Medics administer the first......

NSE to include Adani Wilmar, Adani Power to few indices from Mar 31

Leading stock exchange NSE has tweaked the constituents of its major indices with Adani Group's two companies -- Adani Wilmar and Adani Power -- all set to make their way into some of the Nifty......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

2022: Be Choosy About Stocks

So which sectors are likely to do well in 2022?Should you focus on domestic economy-related sectors or export-oriented ones? Illustration: Dominic Xavier/Rediff.com   Dalal Street witnessed a......

IPOs listed since Sept down 20% from peak

'Whenever markets rally, the IPO pricing gets aligned to the prevailing market conditions.'Sundar Sethuraman reports. Kindly note the image has only been posted for representational reasons.......